Summary of tumour necrosis factor (TNF) ligands. TNF ligands are presented in literature but not discussed in this review
| Compound | Cancer type | Clinical trials | References |
|---|---|---|---|
| Tetrandrine | Prostate cancer | - | [170] |
| Tannic acid | Embryonic carcinoma | - | [171] |
| Scutellarein | Hepatocellular carcinoma | - | [172] |
| CPT211 | Triple negative breast cancer | - | [173] |
| Apigetrin | Gastric cancer | - | [174] |
| Gentian violet | Cutaneous T-cell lymphoma | - | [175] |
| Compound 3 | Non-small cell lung cancer | - | [176] |
| Pemetrexed※ | Non-small cell lung cancer | NCT01769066 | [177] |
| ASTX660※ | Head and neck squamous cell carcinomas | NCT05245682 | [178] |
| Ruthenium complex 2c | Melanoma; breast cancer, lung cancer | - | [179] |
| MnIII complex | Triple negative breast cancer | - | [180] |
| Erinacine A | Colorectal cancer | - | [181] |
| C20E | Triple negative breast cancer | - | [182] |
| 1,3-diphenyl-2-benzyl-1,3-propanedione (DPBP) | Melanoma | - | [183] |
| Licochalcone B | Melanoma, squamous cell carcinoma | - | [184] |
| Erinacine S | Gastric cancer | - | [185] |
| Cedrol | Glioblastoma | - | [186] |
| 3β-Acetyl-nor-erythrophlamide (C5) | Lung cancer, lymphoma | - | [174] |
| Demethylzeylasteral (T-96) | Prostate cancer | - | [187] |
※ Drugs in clinical trial for different cancer types; -: no data